Insiders · CNSP

Christopher Downs

Chief Financial Officer at CNS Pharmaceuticals, Inc. (CNSP)

Christopher Downs has filed 14 insider reports with the SEC since February 2021, as chief Financial Officer at CNS Pharmaceuticals, Inc. (CNSP) and director at EBET, Inc. (EBET). Christopher Downs made no open-market purchases or sales in the last 12 months. The latest filing, on November 19, 2025, reports grant or award at CNS Pharmaceuticals, Inc. (CNSP).

Filings

14

Companies

2

Bought on market

$74K

Sold on market

None

Companies where Christopher Downs is an insider

Company	Role	Shares held	Bought	Sold	Avg buy	Price now	Last filing
CNSP CNS Pharmaceuticals, Inc.	Chief Financial Officer	103,438	$74K		$0.70	$2.89+313%	Nov 19, 2025
EBET EBET, Inc.	Director	6,300					Feb 10, 2023

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record. Price now: the latest daily close, against the average buy price.

Every filing

• Nov 17, 2025
  CNSPSEC Form 4 filed by Chief Financial Officer Downs Christopher

  Form 4Grant or award
• Apr 8, 2024
  CNSPSEC Form 4 filed by Downs Christopher

  Form 4Grant or award
• Feb 1, 2024
  CNSPDowns Christopher bought $20,000 worth of shares (66,666 units at $0.30), increasing direct ownership by 181% to 103,438 units

  Form 4/AGrant or awardOpen-market purchase
  +$20K
• Aug 22, 2023
  CNSPSEC Form 4: Downs Christopher bought $34,177 worth of shares (27,000 units at $1.27), increasing direct ownership by 276% to 36,772 units

  Form 4Open-market purchase
  +$34.2K
• Apr 28, 2023
  CNSPSEC Form 4 filed by Downs Christopher

  Form 4Exercise or conversion of a derivative
• Apr 17, 2023
  CNSPSEC Form 4 filed by Downs Christopher

  Form 4Open-market purchase
  +$9,920
• Mar 29, 2023
  CNSPSEC Form 4 filed by Downs Christopher

  Form 4Grant or award
• Feb 9, 2023
  EBETSEC Form 4: Downs Christopher converted options into 6,300 shares

  Form 4Exercise or conversion of a derivative
• Apr 28, 2022
  CNSPSEC Form 4 filed by Downs Christopher

  Form 4Grant or award
• Mar 11, 2022
  CNSPSEC Form 4: Downs Christopher was granted 33,000 shares, increasing direct ownership by 22% to 184,500 units

  Form 4Grant or award
• Feb 9, 2022
  EBETSEC Form 4 filed by Downs Christopher

  Form 4Grant or award
• Dec 6, 2021
  CNSPSEC Form 4: Downs Christopher bought $4,702 worth of shares (5,000 units at $0.94), increasing direct ownership by 3% to 151,500 units

  Form 4Open-market purchase
  +$4,702
• Nov 19, 2021
  CNSPSEC Form 4: Downs Christopher bought $5,192 worth of shares (4,500 units at $1.15), increasing direct ownership by 3% to 146,500 units

  Form 4Open-market purchase
  +$5,192
• Feb 5, 2021
  CNSPSEC Form 4 filed by Christopher Downs

  Form 4Grant or award

Compare Christopher Downs with

• Christopher Downs vs Michal Fisher1 shared
• Christopher Downs vs Rami Levin1 shared
• Christopher Downs vs Faith L. Charles1 shared
• Christopher Downs vs Eric Faulkner1 shared
• Christopher Downs vs Steve O'Loughlin1 shared
• Christopher Downs vs Jeffry R. Keyes1 shared

Other insiders at the same companies

• Michal FisherCNSP
• Rami LevinCNSP
• Faith L. CharlesCNSP
• Eric FaulknerCNSP
• Steve O'LoughlinCNSP
• Jeffry R. KeyesCNSP
• Amy MaheryCNSP
• John M ClimacoCNSP
• Bettina M. CockroftCNSP
• Jerzy GumulkaCNSP

Questions about Christopher Downs

What is Christopher Downs's role at CNS Pharmaceuticals, Inc.?

Christopher Downs reports to the SEC as chief Financial Officer at CNS Pharmaceuticals, Inc. (CNSP), according to the latest filing on November 19, 2025. Christopher Downs has also filed as director at EBET, Inc. (EBET).

How many shares does Christopher Downs own?

After the latest filing that states it, Christopher Downs directly owned 103,438 shares of CNS Pharmaceuticals, Inc. (CNSP) and 6,300 shares of EBET, Inc. (EBET). Shares held through trusts, funds or family members are reported separately and are not counted here.

Has Christopher Downs bought or sold stock recently?

The most recent open-market purchase was on February 1, 2024: bought 66,666 shares of CNS Pharmaceuticals, Inc. (CNSP) for $20K at an average of $0.30.

How do I get alerts when Christopher Downs files?

Follow Christopher Downs on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Christopher Downs (SEC CIK 0001705978). Totals count each trade once, skipping amendments whose original is on file, from Feb 9, 2021 on. View on SEC EDGAR